Computational pharmaceutical analysis of anti-Alzheimer's Chinese medicine Coptidis Rhizoma alkaloids

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 142-147

  Hong, Hong Jye ^a   Chen, P O Yuan ^b   Shih, Tzu Ching ^c   Ou, Che Yen ^b   Jhuo, Mien D E ^b   Huang, Yen Y U ^b   Cheng, Chia Hsing ^b   Wu, Y U Chi ^b   Chung, Jing Gung ^b,d  

^a School of Chinese Medicine   (Taiwan)

^b Immunology and Biopharmaceutics   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

AChE inhibitors; Alzhimer's disease; Coptidis rhizoma alkaloids

Indexed keywords

ALKALOID; ANTIALZHEIMER AGENT; BERBERINE; CHOLINESTERASE INHIBITOR; COPTISINE; DONEPEZIL; EPIBERBERINE; GALANTAMINE; GROENLANDICINE; JATRORRHIZINE; PALMATINE; RIVASTIGMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHINESE MEDICINE; COMPUTATIONAL PHARMACEUTICAL ANALYSIS; CONTROLLED STUDY; COPTIS; DRUG DETERMINATION; DRUG EFFICACY; DRUG ISOLATION; NEUROPROTECTION; PHYSICAL CHEMISTRY; THEORETICAL STUDY;

ACETYLCHOLINESTERASE; ALKALOIDS; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BINDING SITES; CATALYTIC DOMAIN; CHOLINESTERASE INHIBITORS; COMPUTER SIMULATION; COPTIS; DRUGS, CHINESE HERBAL; HUMANS; MOLECULAR SEQUENCE DATA; RHIZOME; SEQUENCE ALIGNMENT; SOFTWARE;

EID: 84855237904     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.630     Document Type: Article

References (18)

1. Dorronsoro C, Barbero S, Llorente L, et al.: On-eye measurement of optical performance of rigid gas permeable contact lenses based on ocular and corneal aberrometry. Optom Vis Sci 80: 115-125, 2003. (Pubitemid 36222885)
2. Guo T and Hobbs DW: Development of BACE1 inhibitors for Alzheimer's disease. Curr Med Chem 13: 1811-1829, 2006. (Pubitemid 43871758)
3. Parihar MS and Hemnani T: Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 11: 456-467, 2004. (Pubitemid 38869470)
4. Rao AA, Sridhar GR and Das UN: Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med Hypotheses 69: 1272-1276, 2007.
5. Wood KE, Becker BN, McCartney JG, et al.: Care of the potential organ donor. N Engl J Med 351: 2730-2739, 2004. (Pubitemid 39665326)
6. Jacobsen JS, Reinhart P and Pangalos MN: Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease. NeuroRx 2: 612-626, 2005. (Pubitemid 41393269)
7. Mori F, Fukaya M, Abe H, et al.: Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. Neurosci Lett 285: 57-60, 2000. (Pubitemid 30224623)
8. Barril X, Orozco M and Luque FJ: Towards improved acetylcholinesterase inhibitors: a structural and computational approach. Mini Rev Med Chem 1: 255-266, 2001.
9. Jann MW: Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12, 2000.
10. Zarotsky V, Sramek JJ and Cutler NR: Galantamine hydrobromide: an agent for Alzheimer's disease. Am J Health Syst Pharm 60: 446-452, 2003. (Pubitemid 36752907)
11. Hshieh TT, Fong TG, Marcantonio ER, et al.: Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 63: 764-772, 2008.
12. Huang KC (ed.): The Pharmacology of Chinese Herbs. CRC Press Inc., Boca Raton, 1999.
13. Kim DK, Lee KT, Baek NI, et al.: Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch Pharm Res 27: 1127-1131, 2004.
14. Asai M, Iwata N, Yoshikawa A, et al.: Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun 352: 498-502, 2007. (Pubitemid 44838513)
15. Bouzida D, Arthurs S, Colson AB, et al.: Thermodynamics and kinetics of ligand-protein binding studied with the weighted histogram analysis method and simulated annealing. Pac Symp Biocomput: 426-437, 1999.
16. Muegge I and Martin YC: A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem 42: 791-804, 1999. (Pubitemid 29136170)
17. Sussman JL, Harel M, Frolow F, et al.: Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine- binding protein. Science 253: 872-879, 1991. (Pubitemid 21917225)
18. Ferrari D, Yang LH, Miles EW, et al.: Beta D305A mutant of tryptophan synthase shows strongly perturbed allosteric regulation and substrate specificity. Biochemistry 40: 7421-7432, 2001. (Pubitemid 32578006)